Security key
G52441105
KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS)
CUSIP: G52441105
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 58,434,462
- Total 13F value
- $1,173,262,884
- Share change
- +1,918,302
- SEC-reported price per share
- $19.93
- Number of holders
- 101
- Value change
- +$30,753,131
- Number of buys
- 56
- Number of sells
- 45
- Shares outstanding
- 58,457,647
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
101
Top holders
10
KMTS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC filings
KESTRA MEDICAL TECHNOLOGIES, LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G52441105
Recent filing periods:
Ownership snapshot
Top reported holders of KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bain Charger Holdings, L.P.
Disclosed value leader
BAIN CAPITAL INVESTORS LLC
Comparable rows
15/15
Latest evidence
26 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 43%
13D/G row: Bain Charger Holdings, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Bain Charger Holdings, L.P. leads the comparable SEC ownership view at 43%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bain Charger Holdings, L.P.'s linked filing trail.
Comparable ownership
Top 5
Bain Charger Holdings, L.P.
43%
FMR LLC
10%
Endeavour Medtech Growth II LP
4.2%
Jeffrey Lawrence Schwartz
46%
Raymond W. Cohen
0.09%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bain Charger Holdings, L.P. |
13D/G
|
43%
|
$554,798,330
25,172,338 shares
|
-$40,705,389 | 31 Dec 2025 |
| FMR LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$155,185,599
5,851,644 shares
|
— | 31 Dec 2025 |
| Endeavour Medtech Growth II LP |
13D/G
|
4.2%
|
$53,974,682
2,448,942 shares
|
-$4,362,972 | 31 Dec 2025 |
| Jeffrey Lawrence Schwartz |
3/4/5
Director, 10%+ Owner
|
46%
|
$429,508,829
27,030,134 shares
|
— | 04 Sep 2025 |
| Raymond W. Cohen |
3/4/5
Director
|
0.09%
|
$1,017,041
50,903 shares
|
+$199,800 | 26 Mar 2026 |
| Mary Kay Ladone |
3/4/5
Director
|
0.04%
|
$379,818
23,903 shares
|
— | 04 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
101
Shares
58,434,462
Rows available
101
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
108
Q1 2026 holders
101
Holder diff
-7
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend